Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Timing of Immunotherapy and Effective Administration (TIMED): Effects of Infusion Timing on Treatment Response in Solid Tumors
This study evaluates whether the time of day when immunotherapy is given affects clinical outcomes. It includes patients eligible for PD-1 (programmed cell dea…
Lung CancerNon-small Cell Lung CancerMetastatic Lung Cancer+4 more
Estimated
~$10 – $6,250
UNC Lineberger Comprehensive Cancer CenterNCT07630168
Phase 1
Phase I Decitabine Dose-Tolerance in Surgically Resectable HPV-Negative Head and Neck Cancer
This phase I trial tests the safety, side effects, and best dose of decitabine in combination with standard of care surgery, radiation, and/or chemotherapy and…
Human Papillomavirus-Negative Neck Squamous Cell CarcinomaResectable Head and Neck Squamous Cell CarcinomaResectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma+2 more
Estimated
~$10 – $6,250
Mayo ClinicNCT06997094